|
|
P B Jenkins, G K Abou-Alfa, D Dhermy, E Bursaux, C Féo, A L Scarpa, S E Lux, M Garbarz, B G Forget, P G Gallagher
J Clin Invest. 1996;
97(2):373
doi:10.1172/JCI118425
Abstract |
Full text
| PDF

W
e studied a French kindred with typical hereditary spherocytosis (HS). Studies of erythrocytes and erythrocyte membranes from HS individuals revealed abnormal erythrocyte membrane mechanical stability as well as 15-20% deficiency of band 3, the anion transporter. Anion transport studies of red cells from two affected individuals revealed decreased sulfate flux. Nucleotide sequence of cDNA encoding the distal third of the cytoplasmic domain and the entire transmembrane domain of band 3 obtained by RT-PCR of reticulocyte RNA of an affected family member was normal. Sequence analysis of genomic DNA from an HS individual identified a nonsense mutation of the band 3 gene, Q330X, near the end of the band 3 cytoplasmic domain. This mutation was present in genomic DNA of all HS family members and absent in DNA of unaffected family members. Using an RT-PCR-based assay, a marked quantitative decrease in accumulation of the mutant band 3 RNA was detected. Thus the codon 330 nonsense mutation is responsible for the decreased accumulation of mutant band 3 RNA and the deficiency of band 3 protein in this kindred. These results have important implications for the role of band 3 defects in the membrane pathobiology of HS as well as for the techniques used in detection of HS mutations.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(10)
| Title and authors |
Publication |
Year |
Arginine 490 is a hot spot for mutation in the band 3 gene in hereditary spherocytosis
Paulo Roberto Moura Lima, Teresa Sueko Ide Sales, Fernando Ferreira Costa, Sara Teresinha Olalla Saad
|
European Journal of Haematology
|
2009 |
Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease
Mehrdad Khajavi, Ken Inoue, James R Lupski
|
Eur J Hum Genet
|
2006 |
Alterations in band 3 protein and anion exchange in red blood cells of renal failure patients
Varadharaj Saradhadevi, Ramasamy Sakthivel, Srikanth Vedamoorthy, Ramasamy Selvam, Narasimham Parinandi
|
Mol Cell Biochem
|
2005 |
Trafficking and Folding Defects in Hereditary Spherocytosis Mutants of the Human Red Cell Anion Exchanger
Janne A. Quilty, Reinhart A.F. Reithmeier
|
Traffic
|
2000 |
Mutations in the Lysyl Hydroxylase 1 Gene That Result in Enzyme Deficiency and the Clinical Phenotype of Ehlers–Danlos Syndrome Type VI
Heather N. Yeowell, Linda C. Walker
|
Molecular Genetics and Metabolism
|
2000 |
Erythroid band 3 variants and disease
Lesley J Bruce, Michael J.A Tanner
|
Best Practice & Research Clinical Haematology
|
1999 |
Red blood cell membrane disorders
William T. Tse, Samuel E. Lux
|
British Journal of Haematology
|
1999 |
The correlation between microscopical examination and erythrocyte band 3 (AE1) gene deletion in south-east Asian ovalocytosis
C.S. Mgone, B. Genton, W. Peter, M.M. Paniu, M.P. Alpers
|
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
1998 |
Amino-acid substitution in α-spectrin commonly coinherited with nondominant hereditary spherocytosis
William T. Tse, Patrick G. Gallagher, Patricia B. Jenkins, Yongping Wang, Lori Benoit, David Speicher, John C. Winkelmann, Peter Agre, Bernard G. Forget, Sally L. Marchesi
|
Am. J. Hematol.
|
1997 |
Hematologically Important Mutations: Band 3 and Protein 4.2 Variants in Hereditary Spherocytosis
Patrick G. Gallagher, Bernard G. Forget
|
Blood Cells, Molecules, and Diseases
|
1997 |
|